Description

Product details

Seizmet TRIO 0.3 Glimepiride (2mg), Metformin SR (500mg), Voglibose (0.3mg) Seizmet TRIO 0.3 are three medications that can be used together as part of a comprehensive approach to managing type 2 diabetes. They work in different ways to help control blood sugar levels: Glimepiride is a sulfonylurea medication that stimulates the pancreas to release more insulin. It helps lower blood sugar levels by increasing insulin secretion. Glimepiride is typically taken orally as a tablet and is used to enhance insulin secretion in individuals with type 2 diabetes. Metformin SR is a modified-release form of metformin, which belongs to the biguanide class of medications. It primarily reduces the production of glucose in the liver and increases the sensitivity of muscle cells to insulin. Metformin SR is usually taken as an oral tablet and is often prescribed as a first-line treatment for type 2 diabetes. Voglibose is an alpha-glucosidase inhibitor medication. It works by slowing down the digestion and absorption of carbohydrates in the digestive tract. This delay in carbohydrate absorption helps to prevent rapid spikes in blood sugar levels after meals. Voglibose is typically taken orally before meals as a tablet. The combination of these three medications can offer a more comprehensive approach to managing type 2 diabetes. Glimepiride helps stimulate insulin release, Metformin SR improves insulin sensitivity and reduces glucose production, and Voglibose delays carbohydrate absorption, particularly after meals. This combination may be prescribed when blood sugar levels are not adequately controlled with a single medication. For further information: EMAIL: info@sterispharma.com / contact@sterispharma.com CALL/WHATSAPP: 7877551268, 7849827488 Order NOW https://www.sterisonline.com/product/seizmet-trio-0-3-133446